neurocrine.com (NBIX) Narxning prognoz qilingan daromadga nisbati

Neurocrine Corp (NBIX) korporativ emblemasi va logotipi

Neurocrine Biosciences (NBIX) kompaniyasining fundamental muvaffaqiyati Ingrezza preparatining diskineziya terapiyasidagi ustunligiga va FDA tomonidan yangi molekulalar tasdiqlanganligiga bog'liq. Oldingi sotuvlar nisbati (price-to-sales ratio) bozor kutganlarini aniq ko'rsatadi, bunda ko'rsatkich 3.30 darajasida turibdi. Analoglar yo'qligi bemorlarning doimiy ravishda kelishini ta'minlaydi, global sog'liqni saqlash gigantlari bilan strategik sheriklik va qo'shma tadqiqotlar esa innovatsiyalarni tezlashtiradi.

Neurocrine - NBIX Bozor kapitallashuvining kelajakdagi daromadga nisbati (davr: 04.07.2022 - 18.11.2026)

Neurocrine Biosciences (NBIX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:NBIX (neurocrine.com)
Neurocrine Corp tovar namunasi

Keltirilgan P/S koeffitsiyenti kompaniyaning bozor qiymatini uning kutilayotgan savdo hajmi bilan nisbatda belgilaydi, bu esa aktivning haddan tashqari qimmat baholanganini yoki yashirin ravishda past baholanganini aniqlash imkonini beradi. Investorlar ushbu koeffitsiyentdan fundamental jihatdan kuchli kompaniyalarni, past koeffitsiyent biznesning yomonlashishidan darak beradigan "qiymat tuzoqlaridan" ajratish uchun foydalanadilar. Neurocrine Biosciences (NBIX) kompaniyasining kelgusidagi savdoga nisbatan narx grafigini tahlil qilishda, daromadning tor dori portfelining patent himoyasiga bog'liqligini va klinik sinovlar bilan bog'liq xatarlarni hisobga olish juda muhimdir.

Raqobatchilar tahlili

Forvard P/S multiplikatori BIIB (Biogen Idec)|Regencell Bioscience - Narxning prognoz qilingan daromadga nisbati|Axsome Therapeutics - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Forvard P/S multiplikatori|CPRX: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori DNLI|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Harmony Biosciences|Biohaven Ltd - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Praxis Corp PRAX|AVXL: Forvard P/S multiplikatori|CBLL (ceribell.com) - Narxning prognoz qilingan daromadga nisbati|PRTA (Prothena Corporation) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori alector.com (ALEC)|Narxning prognoz qilingan daromadga nisbati Annexon, Inc. (ANNX)|OMER - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Voyager Therapeutics Inc - Forvard P/S multiplikatori|Neumora (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori